-- Preview Email Newsletter
| News Tipoffs - Pennsylvania Editors Newsletter for 2026-10-18 ( 8 items ) |
|
American Society of Anesthesiologists Honors Robert E. Johnstone, M.D., FASA, with its Distinguished Service Award (10)
WASHINGTON, Oct. 17 [Category: Medical] -- The American Society of Anesthesiologists posted the following news release:
* * *
American Society of Anesthesiologists Honors Robert E. Johnstone, M.D., FASA, with its Distinguished Service Award
*
SAN DIEGO -- The American Society of Anesthesiologists (ASA) today presented Robert E. Johnstone, M.D., FASA, with its 2025 Distinguished Service Award in recognition of his enduring contributions to the specialty as an accomplished anesthesiologist, educator, researcher and advocate with a career span more PR
Deluzio Concludes October Town Hall Tour Across Western PA in Beaver Falls (10)
WASHINGTON, Oct. 17 -- Rep. Chris Deluzio, D-Pennsylvania, issued the following news release:
* * *
Deluzio Concludes October Town Hall Tour Across Western PA in Beaver Falls
*
BEAVER FALLS, PA - Today, Congressman Chris Deluzio (PA-17) concluded his October Town Hall Tour across Western Pennsylvania in Beaver Falls. Each town hall in Pennsylvania's 17th District was open to the public and the press. More than 200 Western Pennsylvanians joined him across the three stops.
Congressman Deluzio's October Town Hall Tour provided three opportuni more PR
FDA Approves Genentech's Enspryng, a First-in-Class IL-6R Inhibitor, as First, Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (10)
SOUTH SAN FRANCISCO, California, Oct. 17 -- Genentech, a member of the Roche Group, issued the following news release:
* * *
FDA Approves Genentech's Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis) and improvement in diplopia (double vision), with a favorable safety profile, regardless of TED activity or duration
more PR
FDA Approves Roche's Enspryng, a First-in-class IL-6R Inhibitor, as First, Only At-home Subcutaneous Treatment Option for Thyroid Eye Disease (10)
BASEL, Switzerland, Oct. 17 (TNSjou) -- Roche, a biotech company, issued the following news release:
* * *
FDA approves Roche's Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease
* FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis) and improvement in diplopia (double vision), with a favourable safety profile, regardless of TED activity or duration/1,2
* Enspryng (satralizumab) more PR
ICYMI: Pa. Gov. Shapiro Secures Billions in Private Sector Investments From Life Sciences Companies, Spearheads Largest PhilaPort Expansion in History (10)
HARRISBURG, Pennsylvania, Oct. 17 -- Gov. Josh Shapiro, D-Pennsylvania, issued the following news release:
* * *
ICYMI: Governor Shapiro Secures Billions in Private Sector Investments from Life Sciences Companies, Spearheads Largest PhilaPort Expansion in History
"In just three years, we've worked with the private sector to create nearly 29,000 jobs and secure over $43 billion in private sector investment. That's more than the previous 15 years, combined." -- Governor Shapiro
"This is a job multiplier that will go on for the better part of more PR
Pa. Gov. Shapiro Unveils Pennsylvania's First-Ever Strategic Plan for Agriculture to Support Farmers, Drive Economic Growth, Strengthen Global Competitiveness (10)
HARRISBURG, Pennsylvania, Oct. 17 -- Gov. Josh Shapiro, D-Pennsylvania, issued the following news release:
* * *
Governor Shapiro Unveils Pennsylvania's First-Ever Strategic Plan for Agriculture to Support Farmers, Drive Economic Growth, and Strengthen Global Competitiveness
The ten-year plan outlines the necessary steps to address four critical industry needs including access to capital, efficiency and profitability, modernization and innovation, and public engagement.
With more than 48,800 farms contributing over $153 billion a year to th more PR
Previewing Kent State's Golden Experience (10)
KENT, Ohio, Oct. 16 -- Kent State University posted the following news:
* * *
Previewing Kent State's Golden Experience
*
A little October drizzle couldn't dampen the excitement of Kent State University's biggest recruitment event of the year.
More than 2,000 prospective students and their families attended Preview KSU on Oct. 16. They toured the Kent Campus, learned about the university's award-winning academic programs, saw a glimpse of its top-notch dining and residence halls and visited restaurants and shops in downtown Kent, which was more PR
SUMMER RESEARCH FELLOW: Trinity Lin '29 (10)
NEW WILMINGTON, Pennsylvania, Oct. 16 -- Westminster College posted the following news:
* * *
SUMMER RESEARCH FELLOW: Trinity Lin '29
*
As one of 10 students selected for Westminster College's 10th annual Summer Research Fellowship, Trinity Lin, a sophomore biology major from Taipei, Taiwan, spent her summer investigating if green tea extracts can inhibit the growth of some oral bacteria that cause cavities. Lin conducted her research, "Inhibiting Streptococcus Mutans Biofilm Using Peptide Fragments and Green Tea Extract," under the guidanc more PR
|
